Six months hormone therapy in addition to radiotherapy improves prostate cancer survival (Medical Xpress, 7 April 2014)

08 Apr 2014


A French study presented at the 33rd conference of the European Society for Radiotherapy and Oncology in Vienna assessed prostate cancer survival rates for men undergoing radiotherapy combined with androgen deprivation therapy.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story